Country Grants

---

The Fleming Fund country grants programme supports low- and middle-income countries to establish national surveillance systems to improve One Health antimicrobial resistance (AMR) data collection, analysis, sharing and use.

---

By 2022, the Fleming Fund will have helped 24 low- and middle-income countries to build sustainable national surveillance systems to tackle AMR. The increase in data, shared nationally and globally, will form the basis of changes in policy and practice leading to more optimal use of antimicrobial medicines.

Typical first round country grants are allocated for a period of 12-24 months and funding envelopes differ per country based upon the needs and assessed priorities. In some countries, two rounds of grants will be given.

---

What and who can be funded?

Grants are awarded following a competitive application review process. Requests for Proposals (RFPs) are developed together with national AMR Coordination Committees following a detailed scoping and needs assessment supported by Mott MacDonald.

Each RFP differs based on country needs and priorities, as identified in the National Action Plan for AMR but the core of the country grants programme is to strengthen One Health surveillance systems by:

• supporting implementation of surveillance aspects of National Action Plans
• laboratory infrastructure enhancement
• human resource strengthening and workforce reforms

A typical country grant will seek to support 4-10 human health surveillance sites (1 National Reference Laboratory and clinical laboratories) and 1-3 animal health laboratories (1 National Reference Laboratory and 1-2 regional sites).

In animal health, grants often start in poultry, with additional objectives of surveillance of antimicrobial use and antimicrobial consumption. In human health, clinical microbiology laboratory capacity for blood cultures is developed at key sentinel sites, with a focus on WHO GLASS priority pathogens, taking a passive surveillance approach.

---